Cecilia J Hillard Selected Research

tetrakis(4-benzoic acid)porphyriniron(III)

4/2003

1-Methyl-4-phenylpyridinium (MPP+)-induced apoptosis and mitochondrial oxidant generation: role of transferrin-receptor-dependent iron and hydrogen peroxide.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Cecilia J Hillard Research Topics

Disease

12	Inflammation (Inflammations) 08/2022 - 10/2005
11	Pain (Aches) 08/2022 - 10/2011
10	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2022 - 12/2013
8	Parkinson Disease (Parkinson's Disease) 12/2021 - 04/2003
5	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 12/2003
4	Obesity 01/2020 - 12/2009
4	Neuroblastoma 10/2005 - 04/2003
3	Hyperalgesia 01/2022 - 10/2011
3	Cognitive Dysfunction 01/2020 - 03/2005
3	Neuroinflammatory Diseases 05/2018 - 11/2015
3	Shock 01/2018 - 01/2017
3	Nervous System Diseases (Neurological Disorders) 01/2017 - 09/2007
3	Mood Disorders (Mood Disorder) 09/2009 - 08/2008
2	Fatigue 08/2022 - 01/2019
2	Graft vs Host Disease (Graft-Versus-Host Disease) 08/2022 - 01/2021
2	Anxiety Disorders (Anxiety Disorder) 05/2022 - 09/2012
2	Wounds and Injuries (Trauma) 01/2022 - 05/2021
2	Traumatic Brain Injuries (Traumatic Brain Injury) 12/2021 - 01/2021
2	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 11/2021 - 01/2021
2	Neuralgia (Stump Neuralgia) 01/2021 - 01/2017
2	Substance-Related Disorders (Drug Abuse) 01/2021 - 08/2005
2	Major Depressive Disorder (Major Depressive Disorders) 01/2021 - 01/2019
2	Neoplasms (Cancer) 10/2020 - 12/2004
2	Autoimmune Diseases (Autoimmune Disease) 10/2020 - 04/2007
2	Ataxia (Dyssynergia) 01/2017 - 12/2016
2	Spinocerebellar Ataxias (Spinocerebellar Ataxia) 01/2017 - 12/2016
2	Mental Disorders (Mental Disorder) 11/2016 - 10/2012
2	Amyloid Plaque 11/2015 - 12/2003
2	Cystitis 04/2015 - 10/2011
2	Dyslipidemias (Dyslipidemia) 01/2015 - 12/2009
2	Parkinsonian Disorders (Parkinsonism) 02/2010 - 10/2005
2	Insulin Resistance 12/2009 - 11/2008
2	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 04/2007 - 10/2005
2	Multiple Sclerosis 04/2007 - 02/2007
1	Leukemia 08/2022
1	Cushing Syndrome 01/2022
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2022
1	Stroke (Strokes) 12/2021
1	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2021
1	Bronchiolitis Obliterans Syndrome 01/2021
1	Chronic Pain 01/2021
1	Prolonged Grief Disorder 10/2020
1	Familial cyclic vomiting syndrome 01/2020
1	Confusion (Bewilderment) 01/2019
1	Corneal Injuries 01/2019

Drug/Important Bio-Agent (IBA)

32	EndocannabinoidsIBA 01/2022 - 12/2003
16	CannabinoidsIBA 01/2022 - 12/2003
10	fatty-acid amide hydrolase (fatty acid amide hydrolase)IBA 01/2018 - 12/2003
8	Cannabinoid Receptors (Cannabinoid Receptor)IBA 11/2021 - 05/2006
6	LipidsIBA 01/2021 - 08/2005
6	glyceryl 2-arachidonate (2-arachidonoylglycerol)IBA 01/2020 - 12/2004
5	CB1 Cannabinoid Receptor (CB1 Receptor)IBA 01/2018 - 12/2004
5	EnzymesIBA 01/2017 - 04/2003
4	cyclohexyl carbamic acid 3'-carbamoylbiphenyl-3-yl ester (URB597)IBA 01/2018 - 10/2011
4	anandamide (arachidonylethanolamide)IBA 01/2018 - 06/2010
3	CytokinesIBA 08/2022 - 11/2015
3	Amyloid (Amyloid Fibrils)IBA 01/2022 - 11/2015
3	CB2 Cannabinoid ReceptorIBA 01/2022 - 10/2005
3	Neuroprotective AgentsIBA 12/2021 - 12/2010
3	CannabidiolIBA 09/2021 - 12/2008
3	LeptinIBA 01/2020 - 01/2015
3	Glutamic Acid (Glutamate)FDA Link 12/2016 - 03/2004
3	Fatty Acids (Saturated Fatty Acids)IBA 10/2011 - 09/2007
3	1-Methyl-4-phenylpyridinium (1 Methyl 4 phenylpyridinium)IBA 10/2005 - 04/2003
3	NeurotoxinsIBA 10/2005 - 04/2003
2	tocilizumab (atlizumab)FDA Link 08/2022 - 01/2021
2	enhanced green fluorescent proteinIBA 01/2022 - 05/2018
2	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2022 - 12/2013
2	gamma-Aminobutyric Acid (GABA)IBA 01/2021 - 03/2004
2	Glucose (Dextrose)FDA LinkGeneric 12/2016 - 12/2009
2	GlucocorticoidsIBA 01/2015 - 12/2013
2	Insulin (Novolin)FDA Link 01/2015 - 12/2009
2	AntioxidantsIBA 12/2010 - 04/2003
2	RotenoneIBA 02/2010 - 10/2005
2	Messenger RNA (mRNA)IBA 02/2010 - 10/2005
2	alpha-SynucleinIBA 02/2010 - 04/2004
2	Oxidants (Oxidizing Agents)IBA 02/2010 - 04/2004
2	Adenosine (Adenocard)FDA LinkGeneric 12/2008 - 05/2006
2	Lipoproteins (Lipoprotein)IBA 09/2007 - 09/2007
2	IronIBA 04/2004 - 04/2003
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 08/2022
1	OrexinsIBA 05/2022
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2022
1	3- (1,1- dimethyl- heptyl)- 1- hydroxy- 9- methoxy- benzo(c)chromen- 6- oneIBA 01/2022
1	CB2 receptor agonist LY2828360IBA 01/2022
1	Hormones (Hormone)IBA 01/2022
1	2- ((2,4- dichlorphenyl)amino)- N- ((tetrahydro- 2H- pyran- 4- yl)methyl)- 4- (trifluoromethyl)- 5- pyrimidinecarboxamideIBA 12/2021
1	Oxidopamine (6 Hydroxydopamine)IBA 12/2021
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 10/2021
1	Dronabinol (THC)FDA LinkGeneric 09/2021
1	Biological ProductsIBA 05/2021
1	InterleukinsIBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 10/2020
1	methylamphotericin B (AME)IBA 01/2020
1	AntiemeticsIBA 01/2020
1	Dihydrotachysterol (AT 10)IBA 01/2019
1	Naltrexone (ReVia)FDA LinkGeneric 01/2018

Therapy/Procedure

3	Therapeutics 01/2021 - 07/2017
2	Drug Therapy (Chemotherapy) 01/2022 - 01/2017
1	Hematopoietic Stem Cell Transplantation 01/2021